BJQ-14173-78375
4 vaccinations
6 coded responses
47 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 221 / VA
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
4Z3-27159-54539
Child or adolescent in my care · Male · 2022-06-22
LRD-15013-86833
Child or adolescent in my care · Male · 2022-07-28
Timeline
-
2021-04-02
Dose 1 — Pfizer-BioNTech
-
2021-04-05
Registered in v-safe
-
2021-04-05
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Good · Site: PainFree text: Runny nose (likely allergies)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Survey response — days 1–6 daily, dose 1MedDRA: Hypersensitivity, Rhinorrhoea — Feeling: Fair · Site: Pain · HeadacheFree text: Runny nose (allergies)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease, Rhinorrhoea — Feeling: FairFree text: Runny nose (allergies)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-08
-
2021-04-09
Survey response — day 7, dose 1MedDRA: Cough, Rhinorrhoea — Feeling: GoodFree text: Runny nose and cough (allergies)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-16
-
2021-04-23
Dose 2 — Pfizer-BioNTech
-
2021-04-23
Survey response — day 0, dose 2MedDRA: Oropharyngeal pain — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body achesFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-10
- 2021-05-14
- 2021-05-23
- 2021-05-28
- 2021-06-04
- 2021-07-23
- 2021-10-22
-
2021-10-23
Dose 3 — Pfizer-BioNTech
- 2021-10-23
-
2021-10-24
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fever · Chills, Muscle or body achesAdult check-in
- 2021-10-25
- 2021-10-26
- 2021-10-27
- 2021-10-28
- 2021-10-29
- 2021-10-30
- 2021-11-06
- 2021-11-13
- 2021-11-20
- 2021-11-27
- 2021-12-06
- 2022-01-22
- 2022-04-23
-
2022-09-09
Dose 4 — ModernaCo-administered: Flu
- 2022-09-09
- 2022-09-10
- 2022-09-11
- 2022-09-12
-
2022-09-16
Survey response — day 7, dose 4MedDRA: Cough, Lymphadenopathy, Rhinorrhoea — Feeling: FairFree text: Runny nose, swollen lymph nodes, coughMedDRA releases: 2024-11 · check-in free text available
- 2022-09-23
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-12-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech | |
| 3 | 2021-10-23 | Pfizer-BioNTech | No |
| 4 | 2022-09-09 | Moderna | Flu |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Runny nose (likely allergies)
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Runny nose (allergies)
Systemic reaction (other): Runny nose (allergies)
Release 7 — day 7, dose 1
Systemic reaction (other): Runny nose and cough (allergies)
Release 7 — day 0, dose 2
Systemic reaction (other): Sore throat
Release 12 — day 7, dose 4
Systemic reaction (other): Runny nose, swollen lymph nodes, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Hypersensitivity | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release